Raymond James Financial Inc Aclaris Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 250,805 shares of ACRS stock, worth $318,522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250,805
Previous 154,351
62.49%
Holding current value
$318,522
Previous $382,000
0.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$18.1 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$12.2 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$11.3 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$6.41 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$6.31 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $84.7M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...